Surgery type for colon cancer spread to the liver
Part of Cancer, Digestive system clinical trials.
This trial compares two surgical approaches for removing liver metastases from colon cancer: anatomical resection versus nonanatomical resection. It aims to see which approach works better for people whose tumors have certain genetic changes or are on the right side of the colon.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 75.
- You have confirmed colon cancer that has spread to the liver, with 1 to 3 liver spots.
- Cancer should be removable with surgery, and scans show no spread outside the liver.
- Your tumor has either KRAS/NRAS/BRAF gene mutations OR is right-sided colon cancer.
- Your body is strong enough for surgery (ECOG 0 to 1) and your blood counts, kidney, and liver tests are within limits.
- You have not had prior chemotherapy-type medicine or prior surgery for metastatic (spread) disease, and you can give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares having one surgery to remove both the colon tumor and liver tumors at the same time versus having two separate surgeries. It aims to find which approach is safer and works better for patients whose cancer has spread only to the liver.
This trial studies people who have liver metastases from cancers other than colorectal cancer and are undergoing surgery to remove them. It aims to gather data on outcomes after liver resection.
This trial studies liver transplantation for people with colorectal cancer that has spread to the liver but cannot be surgically removed. It aims to see if transplant can improve outcomes when the cancer is limited to the liver.
This trial tests whether adding two targeted drugs (serplulimab and bevacizumab) to standard chemotherapy before surgery can improve outcomes for people with colorectal cancer that has spread to the liver. It is for those whose cancer has certain genetic features and is considered resectable.
This study tests a local (targeted) approach for breast cancer that has spread to the liver. It looks at whether treating liver metastases with planned liver surgery, along with standard cancer treatment before and after, can improve outcomes.
This trial tests whether treating liver tumors with surgery or ablation can help people whose colorectal cancer has spread to the liver and other organs. It may be an option if you've had only 1 or 2 types of chemotherapy and your non-liver metastases are stable.
Hear when a new Colorectal Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.